| Contingency Management of Alcohol Abuse in the Severely Mentally ILL (NCT01567943) | University of Washington | 2012-03-01 |
| The Efficacy of REHACOP Program in Schizophrenia (NCT02796417) | University of Deusto | 2012-03-01 |
| Body Movement Imitation and Perspective Perception Among Psychiatric Patients (NCT01375894) | Shalvata Mental Health Center | 2012-03-01 |
| Open-label Study of the Efficacy of Intranasal Oxytocin in Schizophrenia (NCT02144155) | University of California, San Diego | 2012-03-01 |
| Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia (NCT02137993) | HK inno.N Corporation | 2012-03-01 |
| Web-Based Weight Management for Individuals With Mental Illness (NCT01324973) | University of California, Los Angeles | 2012-03-01 |
| Magnetic Seizure Therapy (MST) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive Disorder (NCT01596608) | Centre for Addiction and Mental Health | 2012-02-01 |
| Oxytocin MEG Study (NCT02568709) | University of California, San Francisco | 2012-02-01 |
| Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary (NCT01534936) | AstraZeneca | 2012-02-01 |
| Minocycline Augmentation in Schizophrenia (NCT01561742) | The University of Texas Health Science Center, Houston | 2012-02-01 |
| Therapeutic Efficacy of Transcranial Magnetic Stimulation in Schizophrenia (NCT01551979) | Beth Israel Deaconess Medical Center | 2012-02-01 |
| Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone (NCT01516424) | Marubeni Pharmaceuticals (Suzhou) Co., Ltd. | 2012-02-01 |
| The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia (NCT04076371) | Beijing HuiLongGuan Hospital | 2012-01-01 |
| Effect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in Schizophrenia (NCT01503359) | Medical University of Lodz | 2012-01-01 |
| Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine (NCT02704962) | Kaohsiung Kai-Suan Psychiatric Hospital | 2012-01-01 |
| Trial and Follow-up of the Efficacy of Two-stage Integrated Treatment for Chinese Schizophrenia Inpatients (NCT02850445) | Guangzhou Psychiatric Hospital | 2012-01-01 |
| Pregablin for Anxiety-comorbidity in Patients With Schizophrenia (NCT01496690) | University of Aarhus | 2012-01-01 |
| Cognitive Remediation Therapy in Schizophrenia: Effects on BDNF Levels (NCT02341131) | Hospital Clinic of Barcelona | 2012-01-01 |
| Pharmacological Approach to Improve the Outcome of Social Cognition Training (NCT01517360) | VA Greater Los Angeles Healthcare System | 2012-01-01 |
| A Comparative Study to Evaluate the Evolution of Medication Satisfaction and Adherence in Patients Unsatisfied With Current Oral Atypical Antipsychotics by Switching Medication to Paliperidone Palmitate (NCT01682161) | Janssen Korea, Ltd., Korea | 2012-01-01 |
| Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (NCT01509053) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2012-01-01 |
| A Prospective, Open-ended, Multi-center Study of Schizophrenia Patients Switching to Zolodine (NCT04975035) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2012-01-01 |
| Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia (NCT01488929) | Targacept Inc. | 2011-12-01 |
| Prevalence of Metabolic Syndrome in Patients With Schizophrenia in Korea (NCT01477918) | Asan Medical Center | 2011-12-01 |
| Prevalence of Dissociative Disorders in Children (NCT01512641) | Centre Hospitalier Universitaire de Nice | 2011-12-01 |
| Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia (NCT01491412) | AstraZeneca | 2011-12-01 |
| Cerebral Reorganization in Schizophrenia (NCT01781000) | University of Konstanz | 2011-12-01 |
| The Topical Niacin Skin Flush Test in First Episode Psychosis (NCT01324297) | Nova Scotia Health Authority | 2011-12-01 |
| Characterization of Emotional Processing of Information in Bipolar Disorder and Schizophrenic Patients (NCT02841345) | University Hospital, Grenoble | 2011-12-01 |
| A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia (NCT01493726) | Alkermes, Inc. | 2011-12-01 |
| Switching From Consta® to Sustenna® in Patients With Schizophrenia (NCT01698216) | Seoul National University Hospital | 2011-12-01 |
| Study of a Novel Antipsychotic ITI-007 in Schizophrenia (NCT01499563) | Intra-Cellular Therapies, Inc. | 2011-12-01 |
| Risperidone and Desipramine in Alcohol Use and Schizophrenia (NCT01411085) | Dartmouth-Hitchcock Medical Center | 2011-12-01 |
| A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia (NCT01469039) | Alkermes, Inc. | 2011-12-01 |
| A Long-Term Study in Schizophrenia (NCT01487083) | Eli Lilly and Company | 2011-12-01 |
| Life Goals Collaborative Care to Improve Health Outcomes in Mental Disorders (NCT01487668) | VA Office of Research and Development | 2011-12-01 |
| Effects of Acute Nicotine Treatment on Neuroplasticity and Memory in Patients With Schizophrenia (NCT01465074) | Centre for Addiction and Mental Health | 2011-11-01 |
| A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-04958242 In Psychiatrically Stable Subjects With Schizophrenia (NCT01518894) | Biogen | 2011-11-01 |
| Social Cognition in Longstanding Psychosis (NCT01624831) | University of Arizona | 2011-11-01 |
| High Dose D-Serine as Adjuvant Treatment for Recent Onset Schizophrenia (NCT01459029) | Hadassah Medical Organization | 2011-11-01 |
| A Physical Dependence Study in Schizophrenia (NCT01452919) | Denovo Biopharma LLC | 2011-11-01 |
| Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care (NCT01431326) | Daniel Benjamin | 2011-11-01 |
| Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia (NCT01457339) | Shire | 2011-10-21 |
| Bergen Psychosis Project 2 - The Best Intro Study (NCT01446328) | Haukeland University Hospital | 2011-10-01 |
| A Shared Decision-making Training for Inpatients With Schizophrenia (NCT02349880) | Technical University of Munich | 2011-10-01 |
| Guideline vs Usual Treatment in Schizophrenic Adolescents (NCT02573701) | Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico | 2011-10-01 |
| Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients (NCT01448499) | Geha Mental Health Center | 2011-10-01 |
| A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia (NCT01451164) | Otsuka Pharmaceutical Co., Ltd. | 2011-10-01 |
| High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia (NCT01569659) | Northwestern University | 2011-10-01 |
| Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With Olanzapine (NCT01491490) | GW Research Ltd | 2011-10-01 |
| A Long-term Trial of OPC-34712 in Patients With Schizophrenia (NCT01456897) | Otsuka Pharmaceutical Co., Ltd. | 2011-10-01 |
| Reducing Internalized Stigma in People With Serious Mental Illness (NCT01259427) | VA Office of Research and Development | 2011-10-01 |
| A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia (NCT01412060) | Forest Laboratories | 2011-09-27 |
| PEARL Schizophrenia Maintenance (NCT01435928) | Sumitomo Pharma America, Inc. | 2011-09-01 |
| Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole (NCT01432444) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2011-09-01 |
| Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate (NCT01448720) | Janssen-Cilag Farmaceutica Ltda. | 2011-09-01 |
| Influence of Emotion in a Test Run Forgetfulness (NCT02547259) | Centre Hospitalier Universitaire de Saint Etienne | 2011-09-01 |
| Ginkgo Biloba Extract for Schizophrenia (NCT01524380) | Beijing HuiLongGuan Hospital | 2011-09-01 |
| Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia (NCT01246232) | Imperial College London | 2011-09-01 |
| Improving Cognition in Schizophrenia Using Non-invasive Brain Stimulation (NCT04184830) | King's College London | 2011-09-01 |
| Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia (NCT01397786) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2011-09-01 |
| Omega-3 Fatty Acids Efficacy in First-episode of Schizophrenia (NCT02210962) | Medical University of Lodz | 2011-09-01 |
| The Imaging Genetic Study of Schizophrenia and Family (NCT01259232) | Kunming Medical University | 2011-09-01 |
| rTMS-induced Cumulative Pattern of sBDNF in Chronic Schizophrenia (NCT01427088) | Jeonbuk Provincial Maeumsarang Hospital | 2011-08-01 |
| Pain and Schizophrenia (NCT01244542) | University Hospital, Strasbourg, France | 2011-08-01 |
| Group Cognitive-behavioral Intervention for Social Anxiety in Schizophrenia (NCT01376596) | Douglas Mental Health University Institute | 2011-08-01 |
| A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia (NCT01394601) | AstraZeneca | 2011-08-01 |
| Decreasing the Use of Unmodified Electroconvulsive Therapy (ECT) in an Indian Hospital (NCT01526395) | Johns Hopkins University | 2011-08-01 |
| The Effect of Paliperidone Palmitate in Schizophrenia (NCT01860781) | Seoul National University Hospital | 2011-08-01 |
| Art Therapy in Acute Schizophrenia (NCT01622166) | Charite University, Berlin, Germany | 2011-08-01 |
| A Study Of The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-05180999 In Healthy Adults (NCT01429740) | Pfizer | 2011-08-01 |
| Gene Promoter DNA Methylations and Their Relationships With Endophenotypes in Patients With Schizophrenia (NCT01362478) | Taipei Medical University WanFang Hospital | 2011-08-01 |
| Social Cognition Training in Schizophrenia (NCT01206842) | Oslo University Hospital | 2011-08-01 |
| Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults (NCT01266174) | Amarantus BioScience Holdings, Inc. | 2011-08-01 |
| Brain Functions Underlying Visuospatial Attention Deficits in Schizophrenia (NCT01399437) | National Institute on Drug Abuse (NIDA) | 2011-07-03 |
| Antidepressant Controlled Trial for Negative Symptoms in Schizophrenia (NCT01032083) | Imperial College London | 2011-07-01 |
| Nicotinic Receptors and Schizophrenia (NCT01400477) | University of Colorado, Denver | 2011-07-01 |
| IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder (NCT01392482) | AstraZeneca | 2011-07-01 |
| Intracellular Tight Junction Permeability in Schizophrenia: Focus on Zonulin (NCT01558570) | University of Maryland, Baltimore | 2011-07-01 |
| Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia (NCT01394471) | University of North Carolina, Chapel Hill | 2011-07-01 |
| Adjunctive Minocycline in Clozapine Treated Schizophrenia Patients (NCT01433055) | University of Maryland, Baltimore | 2011-07-01 |
| Multi-site Communication Deficits in Schizophrenia (NCT01317121) | Universitätsklinikum Hamburg-Eppendorf | 2011-07-01 |
| Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder (NCT01423916) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2011-07-01 |
| Improving Outcomes for Individuals With Serious Mental Illness and Diabetes (NCT01410357) | Case Western Reserve University | 2011-07-01 |
| Repetitive Transcranial Magnetic Stimulation (rTMS) as an add-on Treatment for Resistant Obsessive-compulsive Symptoms in Patients With Schizophrenia (NCT02105064) | Hospital de Clinicas de Porto Alegre | 2011-07-01 |
| Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia (NCT01377233) | H. Lundbeck A/S | 2011-07-01 |
| Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia (NCT01149655) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2011-07-01 |
| Brain Health and Exercise in Schizophrenia (NCT01392885) | BC Mental Health and Addictions Research Institute | 2011-07-01 |
| Transcranial Direct Current Stimulation (tDCS) for Treatment of Negative Syndrome in Patients With Schizophrenia (NCT01378078) | Ludwig-Maximilians - University of Munich | 2011-06-01 |
| A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia (NCT01490567) | Central South University | 2011-06-01 |
| An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia (NCT01662310) | Janssen Research & Development, LLC | 2011-06-01 |
| A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder (NCT01389908) | Shalvata Mental Health Center | 2011-06-01 |
| Repetitive Transcranial Magnetic Stimulation for First-episode Schizophrenia Patients (NCT01370291) | Xijing Hospital | 2011-06-01 |
| L-arginine add-on Therapy in Patients With Schizophrenia (NCT02398279) | Hacettepe University | 2011-06-01 |
| Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia (NCT01813955) | University of Copenhagen | 2011-06-01 |
| Salsalate as an Adjunctive Treatment for Patients With Schizophrenia (NCT01578486) | University of Massachusetts, Worcester | 2011-06-01 |
| Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Repeated Doses of PF-04958242 in Healthy Volunteers (NCT01511510) | Biogen | 2011-06-01 |
| Lurasidone Extended Use Study (NCT01485640) | Sumitomo Pharma America, Inc. | 2011-06-01 |
| Integrated Care Including Assertive Community Treatment in Early Psychosis (NCT02037581) | Universitätsklinikum Hamburg-Eppendorf | 2011-06-01 |
| Antipsychotic Effects of Oxytocin (NCT01621737) | University of California, San Diego | 2011-06-01 |